FDA Releases Draft Guidance on Unapproved Use Communications from Firms to Health Care Providers Read more
Policy and Medicine Compliance Update October 2023 Issue Features: Complex World of Medical Education, FDA Regulation of Laboratory Developed Tests, FDA Post Marketing Requirements, Distinct Roles of Legal and Compliance and Teva’s Generic Price Fixing Settlement Read more